A Study to Measure Calorie Consumption and Usage in Participants With Obesity Using LY3437943

NCT06313528 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

85

Enrollment

INDUSTRY

Sponsor class

Conditions

Obesity

Interventions

DRUG: LY3437943
OTHER: Placebo

Sponsor

Eli Lilly and Company